KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVS) Profit After Tax (2016 - 2025)

Novartis Ag's Profit After Tax history spans 14 years, with the latest figure at $4.0 billion for Q2 2025.

  • On a quarterly basis, Profit After Tax rose 23.97% to $4.0 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $17.8 billion, a 44.96% increase, with the full-year FY2025 number at $14.0 billion, up 16.99% from a year prior.
  • Profit After Tax hit $4.0 billion in Q2 2025 for Novartis Ag, down from $5.9 billion in the prior quarter.
  • Over the last five years, Profit After Tax for NVS hit a ceiling of $6.0 billion in Q2 2021 and a floor of $514.0 million in Q1 2021.
  • Historically, Profit After Tax has averaged $3.2 billion across 5 years, with a median of $4.0 billion in 2022.
  • Biggest five-year swings in Profit After Tax: skyrocketed 164.95% in 2021 and later decreased 29.6% in 2024.
  • Tracing NVS's Profit After Tax over 5 years: stood at $5.0 billion in 2021, then fell by 20.99% to $3.9 billion in 2022, then increased by 17.81% to $4.6 billion in 2023, then rose by 28.69% to $5.9 billion in 2024, then crashed by 32.19% to $4.0 billion in 2025.
  • Business Quant data shows Profit After Tax for NVS at $4.0 billion in Q2 2025, $5.9 billion in Q4 2024, and $3.2 billion in Q2 2024.